Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-01

Clinical Trial Update: Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease [Phase 4]

View source ↗

Summary

This clinical trial update reports on the efficacy and safety of Abelmoschus Manihot for chronic kidney disease in a Phase 4 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abelmoschus Manihot (Abelmoschus manihot)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Chronic Kidney Disease | Phase 4 | Status: UNKNOWN